<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Nutr Metab</journal-id><journal-id journal-id-type="iso-abbrev">Ann Nutr Metab</journal-id><journal-id journal-id-type="publisher-id">ANM</journal-id><journal-title-group><journal-title>Annals of Nutrition &#x00026; Metabolism</journal-title></journal-title-group><issn pub-type="ppub">0250-6807</issn><issn pub-type="epub">1421-9697</issn><publisher><publisher-name>S. Karger AG</publisher-name><publisher-loc>Allschwilerstrasse 10, P.O. Box &#x000b7; Postfach &#x000b7; Case postale, CH&#x02013;4009, Basel, Switzerland &#x000b7; Schweiz &#x000b7; Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.com</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7573915</article-id><article-id pub-id-type="doi">10.1159/000510508</article-id><article-id pub-id-type="publisher-id">anm-0001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Switching Host Metabolism as an Approach to Dampen SARS-CoV-2 Infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Soliman</surname><given-names>Sameh</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Faris</surname><given-names>MoezAlIslam E.</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Ratemi</surname><given-names>Zakaria</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Halwani</surname><given-names>Rabih</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib></contrib-group><aff id="aff1"><sup>a</sup>Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates</aff><aff id="aff2"><sup>b</sup>Department of Clinical Nutrition and Dietetics, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates</aff><aff id="aff3"><sup>c</sup>Facult&#x000e9; de M&#x000e9;decine, Universit&#x000e9; de Montr&#x000e9;al, Montr&#x000e9;al, Qu&#x000e9;bec, Canada</aff><aff id="aff4"><sup>d</sup>Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates</aff><author-notes><corresp id="cor1">*MoezAlIslam E. Faris, Department of Clinical Nutrition and Dietetics, College of Health Sciences, University of Sharjah, University City, Sharjah University City 27272 (United Arab Emirates), <email>mfaris@sharjah.ac.ae</email></corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>9</month><year>2020</year></pub-date><fpage>1</fpage><lpage>7</lpage><history><date date-type="received"><day>15</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>26</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 by S. Karger AG, Basel</copyright-statement><copyright-year>2020</copyright-year><license license-type="free" xlink:href="https://www.karger.com/Services/SiteLicenses"><license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</license-p></license></permissions><abstract><sec><title>Background</title><p>COVID-19 pandemic, a global threat, adversely affects all daily lives, altered governmental plans around the world, and urges the development of therapeutics and prophylactics to avoid the expansion of the viral infection. With the recent gradual opening after long lockdown, several recommendations have been placed, with dietary modification as one of the most important approaches that have been appraised.</p></sec><sec><title>Summary</title><p>Here, we are reviewing how changing the host metabolism, particularly changing the host metabolic state from the carbohydrate-dependent glycolytic state to a fat-dependent ketogenic state, may affect viral replication. Furthermore, the impact of intermittent fasting (IF) in triggering metabolic switch along with the impact of supplementation with medium-chain triglycerides (MCTs) such as lauric acid in repressing the envelope formation and viral replication is also addressed. The amalgamation of IF and a ketogenic diet rich in MCTs is thought to work as a prophylactic measure for normal people and adjunct therapy for infected persons.</p></sec><sec><title>Key Message</title><p>A diet regimen of ketogenic breakfast along with supplementation with two doses of lauric acid-rich MCTs at breakfast and lunch times, followed by 8&#x02013;12-h IF and a dinner rich with fruits and vegetables, could be a potential prophylactic strategy and adjuvant therapy to combat SARS-CoV-2 infections.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Nutrition</kwd><kwd>Metabolic switch</kwd><kwd>COVID-19</kwd><kwd>Ketogenic diet</kwd><kwd>Intermittent fasting</kwd><kwd>Medium-chain triglycerides</kwd></kwd-group><counts><fig-count count="1"/><ref-count count="46"/><page-count count="7"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1_1"><title>Introduction</title><p>The outbreak of the current global pandemic caused by the spread of a novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2; COVID-19) has posed an unprecedented threat to global health and the world economy. COVID-19 has shaken up all daily lives, and governments around the world are encouraging precautionary measures to help stem the spread of infections. With the recent gradual opening after long lockdown, several recommendations have been suggested. Among these, dietary modification is one of the most important approaches that have been discussed to strengthen human immunity against the spread of viral infection [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. However, to propose a special diet during this latent phase of viral spread, it is mandatory to carefully understand the viral-host metabolism relationship.</p><p>In general, viruses are parasites that lack a defined metabolism [<xref rid="B5" ref-type="bibr">5</xref>], thus rely on the host cell metabolism for the acquisition of raw materials and energy necessary for their biological processes [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B5" ref-type="bibr">5</xref>]. Viral infections alter the host metabolism including, in particular, glycolysis and fatty acid synthesis [<xref rid="B6" ref-type="bibr">6</xref>] to initiate an environment required for the replication and spread of the virus in the human body. Alteration of host cell metabolism by viruses is vital to provide specific substrates that are uniquely needed at high levels for virion production and assembly. Virus benefits from the alteration of host metabolism by accessing (i) the host nucleotides for viral genome replication, (ii) amino acids for virion assembly, (iii) carbohydrates as an energy source, and (iv) fatty acids for viral envelope formation and glycoprotein involvement. In fact, the metabolic status of the virus-contracted hosts, their dietary intakes, sex, age, lifestyle, and environmental factors they are exposed to, as well as their medical conditions, all determine the prognosis of the cases and the clinical severity of SARS-CoV-2 infections [<xref rid="B2" ref-type="bibr">2</xref>].</p><p>Initial preliminary data, using the ecological observational study designed at the global level, indicated an inverse relationship between the number of cases/deaths from COVID-19 and the total intakes of fruits and vegetables (Faris et al. 2020, unpublished data). These preliminary findings suggest a role for the dietary intakes and nutritional status in favoring or disfavoring the body environment required for viral growth and replication and signify the importance of dietary factors in the battle against the pandemic infection [<xref rid="B4" ref-type="bibr">4</xref>].</p><p>Interestingly, dietary modifications have been proposed, including fasting and caloric restrictions, as one of the approaches to alter metabolic pathways [<xref rid="B7" ref-type="bibr">7</xref>]. Intermittent fasting (IF) is an ancient practice followed by different populations globally and has different formats, including time-restricted feeding, alternate-day fasting, 5:2 IF (fasting 2 days, each week), and religious forms of IF [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>] such as Ramadan IF [<xref rid="B10" ref-type="bibr">10</xref>]. During IF, the fasting subjects alternate between periods of voluntary abstinence from food and drink. As a result of this alternation in feeding and fasting periods, metabolic alterations consequently occur to cope with the changes in energy supply and energy shortage, respectively. Halting intakes of dietary long-chain fatty acids (LCFA) and supplementation with medium-chain triglycerides (MCTs) can result in negative energy balance and weight loss by increasing host energy expenditure and lipid oxidation, which disfavor the microenvironment of viral replication [<xref rid="B11" ref-type="bibr">11</xref>].</p><p>Metabolic switching by performing special eating and exercise pattern is a well-established strategy that affects the host metabolism and can lead to improving health-related conditions [<xref rid="B12" ref-type="bibr">12</xref>]. Here, we are proposing that designing a dietary regime can switch the host metabolism to inhibit viral replication and invasion. This is a very safe therapeutic and prophylactic approach that can easily be followed by a wide range of individuals with variable comorbidities [<xref rid="B13" ref-type="bibr">13</xref>].</p><sec id="sec2_1"><title>Importance of Host Lipids to SARS-CoV-2 Infections</title><p>It is well understood that fatty acid synthesis is integral for the creation of lipid material in the cell and is vital for increased membrane production as well as other cellular needs [<xref rid="B14" ref-type="bibr">14</xref>]. Importantly, many viruses induce and require fatty acid synthesis for their life cycle [<xref rid="B15" ref-type="bibr">15</xref>]. Throughout this cycle, lipids play essential roles as they mediate the fusion of viral envelopes with host cell membranes, contribute to the formation of the viral replication complex, and generate the energy needed for viral replication [<xref rid="B16" ref-type="bibr">16</xref>]. Inhibition of saturated LCFA synthesis indicates that fatty acid is required for the production of infectious virions [<xref rid="B14" ref-type="bibr">14</xref>]. It appears that fatty acid synthesis is utilized to build the virion envelope [<xref rid="B17" ref-type="bibr">17</xref>], whereas LCFA were found at high levels in the virion envelope [<xref rid="B17" ref-type="bibr">17</xref>]. It is more likely that these LFCFA are paramount for the integrity of the virion envelope and binding to host cells [<xref rid="B17" ref-type="bibr">17</xref>]. Furthermore, it has been reported that fatty acid synthesis is needed to increase the glycoprotein levels of some viruses such as varicella-zoster virus [<xref rid="B18" ref-type="bibr">18</xref>].</p><p>The question now is whether SARS-CoV-2 similarly affects the host lipid metabolism. A better understanding of SARS-CoV-2-induced metabolic alterations may lead to the design of a special dietary approach that can switch the metabolic environment to disfavor the existence of the virus in the human body. Targeting the host metabolic pathway can provide a safer prevention approach that can overcome the challenges of a virus targeting drugs, such as the development of drug resistance.</p><p>To better understand how SARS-CoV-2 can alter the host metabolism, it is important to identify the main features of the virus and its closest match, since no data regarding the SARS-CoV-2-host metabolic changes are available yet. Coronaviruses, including SARS-CoV-2, are enveloped viruses with a nucleocapsid mainly made of phosphorylated nucleocapsid protein embedded inside a phospholipid bilayer envelop. This envelope plays an important role in virus assembly and release, and it is critical for viral pathogenesis [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>]. The viral surface consists of the spike protein of the virus, which is essential for the attachment to the host cell receptor and for initiating infection [<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>].</p><p>Although no data are describing how the host lipid metabolism affects SARS-CoV-2 infection, it has been shown that glycerophospholipids and fatty acids are significantly elevated in coronavirus-infected cells. Besides, coronaviruses attack the host cell intracellular membranes to create specific phospholipids to form replicative organelles suitable for virus genome replication [<xref rid="B23" ref-type="bibr">23</xref>].</p></sec><sec id="sec2_2"><title>Switching the Host Lipid Metabolism Can Stop Virus Replication and Assembly</title><p>A change in the metabolic pathway is called &#x0201c;metabolic switching&#x0201d; [<xref rid="B24" ref-type="bibr">24</xref>]. Among these metabolic alterations, the most significant metabolic change is the shift from the glucogenic/glycolytic pathway (fed state) to the ketogenic pathway in the liver (fast state) [<xref rid="B13" ref-type="bibr">13</xref>]. Switching body metabolism from fed/feasting state to a fasting state involves systemic and cellular remarkable adaptations to the bioenergetic challenges (from glucose to ketogenesis). This can cause an increase in ketones (acetoacetate and &#x003b2;-HB), increase in mitochondrial stress resistance, increase antioxidant defenses, increase autophagy, increase DNA repair, decrease insulin secretion, decrease mTOR, and decrease protein synthesis [<xref rid="B13" ref-type="bibr">13</xref>]. In the absence of current treatment for SARS-CoV-2, a strong interest has emerged regarding the optimization of the intake of dietary factors, specifically lipids, to effectively reduce inflammation and oxidative stress, thus strengthening the immune response during the COVID-19 crisis. Besides, metabolic changes accompanied by IF that trigger antiviral mechanism has been suggested elsewhere [<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>].</p><p>Given the indispensable nature of lipids in multiple stages of viral replication, the modulation of lipid profiles in host cells has been recently proposed as a potential novel strategy to combat human coronaviruses [<xref rid="B16" ref-type="bibr">16</xref>]. Bioactive lipids with antiviral properties cited in the literature include certain long-chain monounsaturated fatty acids (MUFAs) and medium-chain fatty acids (MCFAs), specifically lauric acid (LA). LA, the primary fatty acid of coconut oil, is a saturated MCFA with potent antimicrobial properties [<xref rid="B27" ref-type="bibr">27</xref>]. When ingested, coconut oil is metabolized to produce the metabolite monolaurin [<xref rid="B28" ref-type="bibr">28</xref>].</p><p>Medium-chain saturated fatty acids such as LA and long-chain unsaturated fatty acids (such as oleic acid of olive oil) are highly active against enveloped viruses such as coronavirus [<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>]. Monoglycerides of these fatty acids also show significant antiviral activity. Antiviral fatty acids impact the viral envelope, causing leakage and at higher concentrations can cause a complete disintegration of the viral particles including the viral envelope [<xref rid="B29" ref-type="bibr">29</xref>].</p><p>The antiviral effect of MCFAs including LA has been tested against arenavirus infection; LA showed the most active inhibitory effect against viral replication since it caused a significant decrement in the virus yields of several pathogenic strains in a dose-dependent manner, without affecting the cell viability [<xref rid="B31" ref-type="bibr">31</xref>]. Furthermore, LA was found to inhibit a late maturation stage in the replicative cycle of the Junin virus (JUNV). Viral protein synthesis was not affected by the compound, but the expression of glycoproteins in the plasma membrane was diminished. A direct correlation between the inhibition of JUNV production and stimulation of triacylglycerol cell content was demonstrated. On the other hand, shorter- or longer-chain fatty acids showed a reduced or negligible anti-multiplication effect on the JUNV [<xref rid="B31" ref-type="bibr">31</xref>]. Both triacylglycerol- and LA-induced effects were dependent on the continued presence of fatty acid. Thus, the reduced insertion of viral glycoproteins into the plasma membrane, apparently due to the increased incorporation of triacylglycerols, seems to inhibit JUNV maturation and release [<xref rid="B31" ref-type="bibr">31</xref>].</p><p>The antiviral activity of LA and monolaurin can be achieved through 3 distinct mechanisms. First, LA and monolaurin inactivate viruses by disintegrating the viral envelope, thus reducing the infectivity of RNA and DNA enveloped viruses [<xref rid="B32" ref-type="bibr">32</xref>]. Second, LA inhibits the late maturation stage in the virus replication cycle as demonstrated in a study investigating the LA-mediated inhibition of the Junin virus, which possesses a similar structure to SARS-CoV-2 [<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>]. Third, LA prevents the binding of viral proteins to the host cell membrane as described for infectious <italic>Vesicular stomatitis virus</italic>[<xref rid="B35" ref-type="bibr">35</xref>]. The effectiveness and safety of LA as an antiviral compound against HIV were also suggested [<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>]. The substantial evidence for the antiviral properties of LA (commonly found in coconut oil) is promising and encourages its further investigation as a potential therapeutic agent that is both affordable and clinically innocuous for SARS-CoV-2-infected patients.</p><p>Recent research signified the importance of MCFA supplementation (in the form of C8:0&#x02013;C10:0 MCT supplement) as a way to optimize ketogenicity induced upon metabolic switching [<xref rid="B38" ref-type="bibr">38</xref>]. An 8-h metabolic study protocol was suggested to assess the influence of ketogenic MCT supplement, meal timing, and low-carbohydrate meal on plasma levels of free fatty acids (FFA), blood ketones, glucose, and insulin. Over the 8-h test period, the provision of the study participants with 2 doses of the ketogenic MCT drink (10-g MCT for each dose of the drink) increased the plasma ketone response by 88% while reducing glycemic response by 12%, without changing insulin or FFA levels. Besides, researchers found that subsequent to an overnight fast, an early breakfast was more effective in potentiating the ketogenic effect of metabolic switch over 8 h in comparison with a delayed lunch without breakfast. Researchers concluded that a ketogenic MCT drink can provide a booming short-term increase in plasma levels of ketones under various feeding conditions and might augment the metabolic effects of a short-term metabolic switch or IF [<xref rid="B38" ref-type="bibr">38</xref>].</p></sec><sec id="sec2_3"><title>Switching Lipid Metabolism and Inhibition of Cytokine Storm</title><p>Once SARS-CoV-2 invades the cells, it hijacks the cells' machinery and uses it to ensure its proper replication. This disruption results in damaging the infected cells [<xref rid="B39" ref-type="bibr">39</xref>]. This prompts a local immune response, involving the recruitment of macrophages and monocytes that often readily subsides permitting patients to ultimate recovery [<xref rid="B39" ref-type="bibr">39</xref>]. However, in more severe cases, viral replication triggers an aberrantly strong release of proinflammatory cytokines, a phenomenon termed as a cytokine storm, which causes damage to host tissue and contributes to lung injury and respiratory failure [<xref rid="B39" ref-type="bibr">39</xref>].</p><p>The positive effect of IF in triggering autophagy, and the way how autophagy triggers the innate and adaptive immunity against viral infection, including the SARS-CoV-2, is extensively reviewed [<xref rid="B40" ref-type="bibr">40</xref>]. Hannan and colleagues [<xref rid="B26" ref-type="bibr">26</xref>] reported that fasting can provoke the host defense system through activating multiple physiological processes, including autophagy and immune responses. The pulmonary alveolar epithelial cells that are infected with SARS-CoV-2 release damage-associated molecular patterns such as nucleic acids, which are recognized by adjacent epithelial cells and resident macrophages, prompting the release of proinflammatory cytokines and chemokines (IL-6, IP-10, MIP1&#x003b1;, and MCP1). These mediators attract inflammatory cells, including monocytes, macrophages, and T cells to the site of infection, which normally acts on resolving the viral infection. In case of a dysfunctional immune response, the uncontrolled viral replications, as well as the massive infiltration of inflammatory cells, destroy the airway epithelial cells, resulting in the release of several proinflammatory mediators including IL-1&#x003b2;, IL-6, and TNF-&#x003b1;. Another fasting-mediated cellular process is autophagy that either activates innate and adaptive immunity or degrades viral particles (xenophagy) [<xref rid="B26" ref-type="bibr">26</xref>].</p><p>Besides its direct antiviral effect, MCTs were reported to enhance macrophage phagocytic activity and regulate the expression of several inflammatory mediators [<xref rid="B41" ref-type="bibr">41</xref>]. MCFAs including caprylic, capric, and LAs were also shown to suppress the expression of IL-8 [<xref rid="B41" ref-type="bibr">41</xref>], a proinflammatory cytokine, and the main chemoattractant-driving neutrophil lung infiltration.</p><p>During SARS-CoV-2 infection, the uncontrolled viral replication in lung tissue triggers the release of a wide range of proinflammatory cytokines including IL-1&#x003b2;, IL-6, IL-8, and TNF-&#x003b1; [<xref rid="B39" ref-type="bibr">39</xref>]. Three of the aforementioned cytokines have been reported to be significantly reduced upon IF, which reinforces the hypothesized role of IF in ameliorating the inflammatory background of the infection [<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>]. The infiltration of neutrophils to the airway tissue was widely reported especially in severe stages of the disease. These neutrophils, while attacking infected cells, contribute largely to the destruction of the lung tissue and hence the development of acute respiratory distress syndrome (ARDS). Therefore, by regulating IL-8 expression, MCFAs may limit neutrophil infiltration and hence help to protect lung tissue from the exaggerated immune response.</p><p>Lauric acid, on the other hand, was shown to downregulate the expression of IL-6 in intestinal epithelial cells [<xref rid="B41" ref-type="bibr">41</xref>]. Interleukin-6 is another key proinflammatory cytokine contributing to the cytokine storm observed in most patients with severe COVID-19 symptoms. It is released from macrophages, and dendritic cells are infected with SARS-CoV-2 [<xref rid="B44" ref-type="bibr">44</xref>]. Further, IL-6 triggers the release of vascular endothelial growth factor, CCL2, and IL-8 [<xref rid="B45" ref-type="bibr">45</xref>], causing an upregulation of C-reactive protein blood levels and increased infiltration of macrophages and neutrophils to the inflamed lung tissue. The cytokine suppressive effect of LA suggests that it may help in preventing or at least regulating the uncontrolled wave of proinflammatory cytokine and its devastating systemic effect.</p></sec><sec id="sec2_4"><title>Suggested Diet to Disfavor the Viral Replication and Infection</title><p>Here, we propose a medical hypothesis either as a prophylactic or adjuvant supplement for people infected with SARS-CoV-2. This aims to mitigate the infection by changing the microenvironment of the host metabolism in a way that disfavors viral replication and controls the aggressive nonspecific immune responses. This is based on a metabolic switch accompanied by host lipid metabolism to the ketogenic pathway. Caprylic acid/LA-enriched coconut oil can be used as a ketogenic MCT supplement that is hypothesized to aid in suppressing viral replication and ameliorating the severity of COVID-19 complication. Also, by enhancing macrophage activity, limiting neutrophil infiltration into the lung tissue, as well as suppressing IL-6 cytokine, one of the key players in the cytokine storm observed at later severe stages of the diseases, MCFAs may suppress uncontrolled immune responses.</p><p>This modification of the microenvironment required for viral replication can be accomplished as well by a ketogenic MCT drink rich in LA and low in LCFAs followed by a short-term IF period of 8&#x02013;12 h. For a more practical medical nutrition protocol, here we suggest that healthy individuals, or patients with COVID-19, are suggested to follow the proposed dietary regime indicated below and in Figure <xref ref-type="fig" rid="F1">1</xref>, as a prophylactic or therapeutic approach:
<list list-type="order"><list-item><p>A breakfast enriched with ketogenic MCT via coconut oil enriched with LA/caprylic acid and monounsaturated long-chain fatty acid (oleic acid 18:1 omega-9) from olive oil rich in antioxidant and anti-inflammatory bioactive phytochemicals [<xref rid="B46" ref-type="bibr">46</xref>]. Breakfast with more protein foods prepared with MCT oil (coconut oil) can trigger the ketogenic pathway and hence supposed to repress the viral replication.</p></list-item><list-item><p>Following breakfast supplemented with 20-g ketogenic MCT drink and keeping an 8&#x02013;12 h fasting can trigger the ketogenic pathway and allow for cellular activation of the autophagy pathway and hence proposed to ameliorate the SARS-CoV-2 viral replication. At lunch time, subjects are given 20-g ketogenic MCT drink without a meal.</p></list-item><list-item><p>After the 8&#x02013;12 fasting period, a dinner with a balanced diet can provide the required amount of carbohydrates, and fibers from fruits and vegetables rich in vitamins and minerals are important for boosting the immunity against SARS-CoV-2 infection [<xref rid="B1" ref-type="bibr">1</xref>].</p></list-item></list></p></sec></sec><sec sec-type="conclusions" id="sec1_2"><title>Conclusion</title><p>With the gradual opening after long lockdown because of the COVID-19 pandemic, we are proposing a prophylactic diet regimen that may limit viral levels in the human body. This can be established by switching the host lipid metabolism, critical for viral replication and assembly, by induction of the ketogenic pathway using coconut-rich MCFAs along with olive oil, followed by 8&#x02013;12 h fasting and a dinner rich with fruits and vegetables.</p></sec><sec sec-type="COI-statement" id="sec1_3"><title>Conflict of Interest Statement</title><p>The authors confirm that this article content has no conflicts of interest.</p></sec><sec id="sec1_4"><title>Funding Sources</title><p>The current work did not receive any grant or fund.</p></sec><sec id="sec1_5"><title>Author Contributions</title><p>MoezAlIslam Faris and Sameh Soliman: conception and design of the work; Rabih Halwani: interpretation of findings of the work; MoezAlIslam Faris, Sameh Soliman, and Zakaria Ratemi: drafting the work; Rabih Halwani: revising it critically for important intellectual content. All authors approved the final version to be published.</p></sec></body><back><ack><title>Acknowledgment</title><p>The authors acknowledge the generous support from Sandooq Al Watan and University of Sharjah to Sameh Soliman.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name></person-group><article-title>Nutrition, immunity and COVID-19</article-title><source>BMJ Nutr Prev Health</source><year>2020</year><volume>3</volume><issue>(1)</issue><fpage>74</fpage><lpage>92</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasmi</surname><given-names>A</given-names></name><name><surname>Noor</surname><given-names>S</given-names></name><name><surname>Tippairote</surname><given-names>T</given-names></name><name><surname>Dadar</surname><given-names>M</given-names></name><name><surname>Menzel</surname><given-names>A</given-names></name><name><surname>Bj&#x000f8;rklund</surname><given-names>G</given-names></name></person-group><article-title>Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic</article-title><source>Clin Immunol</source><year>2020</year><volume>215</volume><fpage>108409</fpage><pub-id pub-id-type="pmid">32276137</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iddir</surname><given-names>M</given-names></name><name><surname>Brito</surname><given-names>A</given-names></name><name><surname>Dingeo</surname><given-names>G</given-names></name><name><surname>Fernandez Del Campo</surname><given-names>SS</given-names></name><name><surname>Samouda</surname><given-names>H</given-names></name><name><surname>La Frano</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><issue>(6)</issue><fpage>1562</fpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zabetakis</surname><given-names>I</given-names></name><name><surname>Lordan</surname><given-names>R</given-names></name><name><surname>Norton</surname><given-names>C</given-names></name><name><surname>Tsoupras</surname><given-names>A</given-names></name></person-group><article-title>COVID-19: the inflammation link and the role of nutrition in potential mitigation</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><issue>(5)</issue><fpage>1466</fpage></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villarreal</surname><given-names>L</given-names></name></person-group><article-title>Are viruses alive?</article-title><source>Sci Am</source><year>2005</year><season>Jan 01</season><volume>291</volume><fpage>100</fpage><lpage>5</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>EL</given-names></name><name><surname>Lagunoff</surname><given-names>M</given-names></name></person-group><article-title>Viral activation of cellular metabolism</article-title><source>Virology</source><year>2015</year><season>May 01</season><volume>479&#x02013;80</volume><fpage>609</fpage><lpage>18</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname><given-names>J</given-names></name><name><surname>Manda</surname><given-names>G</given-names></name></person-group><article-title>Metabolic pathways of the Warburg effect in health and disease: perspectives of choice, chain or chance</article-title><source>Int J Mol Sci</source><year>2017</year><volume>18</volume><issue>(12)</issue><fpage>2755</fpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>RE</given-names></name><name><surname>Sears</surname><given-names>DD</given-names></name></person-group><article-title>Metabolic effects of intermittent fasting</article-title><source>Annu Rev Nutr</source><year>2017</year><volume>37</volume><issue>(1)</issue><fpage>371</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">28715993</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Francesco</surname><given-names>A</given-names></name><name><surname>Di Germanio</surname><given-names>C</given-names></name><name><surname>Bernier</surname><given-names>M</given-names></name><name><surname>de Cabo</surname><given-names>R</given-names></name></person-group><article-title>A time to fast</article-title><source>Science</source><year>2018</year><volume>362</volume><issue>(6416)</issue><fpage>770</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">30442801</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faris</surname><given-names>MAIE</given-names></name><name><surname>Jahrami</surname><given-names>HA</given-names></name><name><surname>Alsibai</surname><given-names>J</given-names></name><name><surname>Obaideen</surname><given-names>AA</given-names></name></person-group><article-title>Impact of Ramadan diurnal intermittent fasting on the metabolic syndrome components in healthy, non-athletic Muslim people aged over 15 years: a systematic review and meta-analysis</article-title><source>Br J Nutr</source><year>2020</year><volume>123</volume><issue>(1)</issue><fpage>1</fpage><lpage>22</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mumme</surname><given-names>K</given-names></name><name><surname>Stonehouse</surname><given-names>W</given-names></name></person-group><article-title>Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials</article-title><source>J Acad Nutr Diet</source><year>2015</year><volume>115</volume><issue>(2)</issue><fpage>249</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">25636220</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattson</surname><given-names>MP</given-names></name><name><surname>Moehl</surname><given-names>K</given-names></name><name><surname>Ghena</surname><given-names>N</given-names></name><name><surname>Schmaedick</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name></person-group><article-title>Intermittent metabolic switching, neuroplasticity and brain health</article-title><source>Nat Rev Neurosci</source><year>2018</year><season>Feb 01</season><volume>19</volume><issue>(2)</issue><fpage>63</fpage><lpage>80</lpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Cabo</surname><given-names>R</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name></person-group><article-title>Effects of intermittent fasting on health, aging, and disease</article-title><source>N Engl J Med</source><year>2019</year><volume>381</volume><issue>(26)</issue><fpage>2541</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">31881139</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munger</surname><given-names>J</given-names></name><name><surname>Bennett</surname><given-names>BD</given-names></name><name><surname>Parikh</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>XJ</given-names></name><name><surname>McArdle</surname><given-names>J</given-names></name><name><surname>Rabitz</surname><given-names>HA</given-names></name><etal/></person-group><article-title>Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy</article-title><source>Nat Biotechnol</source><year>2008</year><season>Oct 01</season><volume>26</volume><issue>(10)</issue><fpage>1179</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">18820684</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herker</surname><given-names>E</given-names></name><name><surname>Ott</surname><given-names>M</given-names></name></person-group><article-title>Unique ties between hepatitis C virus replication and intracellular lipids</article-title><source>Trends Endocrinol Metab</source><year>2011</year><season>Jun 01</season><volume>22</volume><issue>(6)</issue><fpage>241</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21497514</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>B</given-names></name><name><surname>Chu</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Sze</surname><given-names>KH</given-names></name><name><surname>Lai</surname><given-names>PM</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Characterization of the lipidomic profile of human coronavirus-infected cells: implications for lipid metabolism remodeling upon coronavirus replication</article-title><source>Viruses</source><year>2019</year><season>Jan 16</season><volume>11</volume><issue>(1)</issue><fpage>73</fpage></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koyuncu</surname><given-names>E</given-names></name><name><surname>Purdy</surname><given-names>JG</given-names></name><name><surname>Rabinowitz</surname><given-names>JD</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><article-title>Saturated very long chain fatty acids are required for the production of infectious human cytomegalovirus progeny</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><issue>(5)</issue><fpage>e1003333</fpage><pub-id pub-id-type="pmid">23696731</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namazue</surname><given-names>J</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Okuno</surname><given-names>T</given-names></name><name><surname>Shiraki</surname><given-names>K</given-names></name><name><surname>Yamanishi</surname><given-names>K</given-names></name></person-group><article-title>Evidence for attachment of fatty acid to Varicella-zoster virus glycoproteins and effect of cerulenin on the maturation of Varicella-zoster virus glycoproteins</article-title><source>Intervirology</source><year>1989</year><volume>30</volume><issue>(5)</issue><fpage>268</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">2551842</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundin</surname><given-names>A</given-names></name><name><surname>Dijkman</surname><given-names>R</given-names></name><name><surname>Bergstr&#x000f6;m</surname><given-names>T</given-names></name><name><surname>Kann</surname><given-names>N</given-names></name><name><surname>Adamiak</surname><given-names>B</given-names></name><name><surname>Hannoun</surname><given-names>C</given-names></name><etal/></person-group><article-title>Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the Middle East respiratory syndrome virus</article-title><source>PLoS Pathog</source><year>2014</year><month>5</month><volume>10</volume><issue>(5)</issue><fpage>e1004166</fpage><pub-id pub-id-type="pmid">24874215</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>BA</given-names></name><name><surname>Graham</surname><given-names>RL</given-names></name><name><surname>Menachery</surname><given-names>VD</given-names></name></person-group><article-title>Viral metagenomics, protein structure, and reverse genetics: key strategies for investigating coronaviruses</article-title><source>Virology</source><year>2018</year><month>4</month><volume>517</volume><fpage>30</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">29279138</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lei</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Mi</surname><given-names>D</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name><etal/></person-group><article-title>Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV</article-title><source>Nat Commun</source><year>2020</year><season>Mar 27</season><volume>11</volume><issue>(1)</issue><fpage>1620</fpage><pub-id pub-id-type="pmid">32221306</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Wall</surname><given-names>A</given-names></name><name><surname>McGuire</surname><given-names>AT</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</article-title><source>Cell</source><year>2020</year><month>4</month><volume>181</volume><issue>(2)</issue><fpage>281</fpage><lpage>92.e3</lpage><pub-id pub-id-type="pmid">32155444</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Nagy</surname><given-names>PD</given-names></name></person-group><article-title>RNA virus replication depends on enrichment of phosphatidylethanolamine at replication sites in subcellular membranes</article-title><source>Proc Natl Acad Sci U S A</source><year>2015</year><volume>112</volume><issue>(14)</issue><fpage>E1782</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">25810252</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>A</given-names></name><name><surname>Truckenbrod</surname><given-names>L</given-names></name><name><surname>Federico</surname><given-names>Q</given-names></name><name><surname>Campos</surname><given-names>K</given-names></name><name><surname>Moon</surname><given-names>B</given-names></name><name><surname>Ferekides</surname><given-names>N</given-names></name><etal/></person-group><article-title>Metabolic switching is impaired by aging and facilitated by ketosis independent of glycogen</article-title><source>Aging</source><year>2020</year><volume>12</volume><issue>(9)</issue><fpage>7963</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">32369441</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faris</surname><given-names>MAIE</given-names></name><name><surname>Salem</surname><given-names>ML</given-names></name><name><surname>Jahrami</surname><given-names>HA</given-names></name><name><surname>Madkour</surname><given-names>MI</given-names></name><name><surname>BaHammam</surname><given-names>AS</given-names></name></person-group><article-title>Ramadan intermittent fasting and immunity: an important topic in the era of COVID-19</article-title><source>Ann Thorac Med</source><year>2020</year><volume>15</volume><issue>(3)</issue><fpage>125</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">32831933</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannan</surname><given-names>MA</given-names></name><name><surname>Rahman</surname><given-names>MA</given-names></name><name><surname>Rahman</surname><given-names>MS</given-names></name><name><surname>Sohag</surname><given-names>AAM</given-names></name><name><surname>Dash</surname><given-names>R</given-names></name><name><surname>Hossain</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: crosstalk among calorie restriction, autophagy and immune response</article-title><source>Immunol Lett</source><year>2020</year><season>Oct 01</season><volume>226</volume><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">32659267</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lappano</surname><given-names>R</given-names></name><name><surname>Sebastiani</surname><given-names>A</given-names></name><name><surname>Cirillo</surname><given-names>F</given-names></name><name><surname>Rigiracciolo</surname><given-names>DC</given-names></name><name><surname>Galli</surname><given-names>GR</given-names></name><name><surname>Curcio</surname><given-names>R</given-names></name><etal/></person-group><article-title>The lauric acid-activated signaling prompts apoptosis in cancer cells</article-title><source>Cell Death Discov</source><year>2017</year><volume>3</volume><fpage>17063</fpage><pub-id pub-id-type="pmid">28924490</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarty</surname><given-names>MF</given-names></name><name><surname>DiNicolantonio</surname><given-names>JJ</given-names></name></person-group><article-title>Lauric acid-rich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicity</article-title><source>Open Heart</source><year>2016</year><volume>3</volume><issue>(2)</issue><fpage>e000467</fpage><pub-id pub-id-type="pmid">27547436</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thormar</surname><given-names>H</given-names></name><name><surname>Isaacs</surname><given-names>CE</given-names></name><name><surname>Brown</surname><given-names>HR</given-names></name><name><surname>Barshatzky</surname><given-names>MR</given-names></name><name><surname>Pessolano</surname><given-names>T</given-names></name></person-group><article-title>Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides</article-title><source>Antimicrob Agents Chemother</source><year>1987</year><volume>31</volume><issue>(1)</issue><fpage>27</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">3032090</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boateng</surname><given-names>L</given-names></name><name><surname>Ansong</surname><given-names>R</given-names></name><name><surname>Owusu</surname><given-names>W</given-names></name><name><surname>Steiner-Asiedu</surname><given-names>M</given-names></name></person-group><article-title>Coconut oil and palm oil's role in nutrition, health and national development: a review</article-title><source>Ghana Med J</source><year>2016</year><volume>50</volume><issue>(3)</issue><fpage>189</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">27752194</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartolotta</surname><given-names>S</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>CC</given-names></name><name><surname>Candurra</surname><given-names>NA</given-names></name><name><surname>Damonte</surname><given-names>EB</given-names></name></person-group><article-title>Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid</article-title><source>Arch Virol</source><year>2001</year><volume>146</volume><issue>(4)</issue><fpage>777</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">11402863</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hierholzer</surname><given-names>JC</given-names></name><name><surname>Kabara</surname><given-names>JJ</given-names></name></person-group><article-title>In vitro effects of monolaurin compounds on enveloped RNA and DNA viruses</article-title><source>J Food Saf</source><year>1982</year><month>3</month><volume>4</volume><issue>(1)</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">32336838</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartolotta</surname><given-names>S</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>CC</given-names></name><name><surname>Candurra</surname><given-names>NA</given-names></name><name><surname>Damonte</surname><given-names>EB</given-names></name></person-group><article-title>Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid</article-title><source>Arch Virol</source><year>2001</year><volume>146</volume><issue>(4)</issue><fpage>777</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">11402863</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>A</given-names></name><name><surname>Seregin</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Kolokoltsova</surname><given-names>O</given-names></name><name><surname>Brasier</surname><given-names>A</given-names></name><name><surname>Peters</surname><given-names>C</given-names></name><etal/></person-group><article-title>Jun&#x000ed;n virus pathogenesis and virus replication</article-title><source>Viruses</source><year>2012</year><season>Oct 19</season><volume>4</volume><issue>(10)</issue><fpage>2317</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">23202466</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornung</surname><given-names>B</given-names></name><name><surname>Amtmann</surname><given-names>E</given-names></name><name><surname>Sauer</surname><given-names>G</given-names></name></person-group><article-title>Lauric acid inhibits the maturation of vesicular stomatitis virus</article-title><source>J Gen Virol</source><year>1994</year><month>2</month><volume>75</volume><issue>(Pt 2)</issue><fpage>353</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">8113756</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardon</surname><given-names>A</given-names></name><name><surname>Desclaux</surname><given-names>A</given-names></name><name><surname>Egrot</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>E</given-names></name><name><surname>Micollier</surname><given-names>E</given-names></name><name><surname>Kyakuwa</surname><given-names>M</given-names></name></person-group><article-title>Alternative medicines for AIDS in resource-poor settings: insights from exploratory anthropological studies in Asia and Africa</article-title><source>J Ethnobiol Ethnomed</source><year>2008</year><season>Jul 10</season><volume>4</volume><fpage>16</fpage><pub-id pub-id-type="pmid">18616794</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirtane</surname><given-names>AR</given-names></name><name><surname>Rothenberger</surname><given-names>MK</given-names></name><name><surname>Frieberg</surname><given-names>A</given-names></name><name><surname>Nephew</surname><given-names>K</given-names></name><name><surname>Schultz-Darken</surname><given-names>N</given-names></name><name><surname>Schmidt</surname><given-names>T</given-names></name><etal/></person-group><article-title>Evaluation of vaginal drug levels and safety of a locally administered glycerol monolaurate cream in rhesus macaques</article-title><source>J Pharm Sci</source><year>2017</year><month>7</month><volume>106</volume><issue>(7)</issue><fpage>1821</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">28389267</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandenberghe</surname><given-names>C</given-names></name><name><surname>St-Pierre</surname><given-names>V</given-names></name><name><surname>Fortier</surname><given-names>M</given-names></name><name><surname>Castellano</surname><given-names>CA</given-names></name><name><surname>Cuenoud</surname><given-names>B</given-names></name><name><surname>Cunnane</surname><given-names>SC</given-names></name></person-group><article-title>Medium chain triglycerides modulate the ketogenic effect of a metabolic switch</article-title><source>Front Nutr</source><year>2020</year><season>Jan 31</season><volume>7</volume><issue>(3)</issue><fpage>3</fpage><pub-id pub-id-type="pmid">32083091</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tay</surname><given-names>MZ</given-names></name><name><surname>Poh</surname><given-names>CM</given-names></name><name><surname>R&#x000e9;nia</surname><given-names>L</given-names></name><name><surname>MacAry</surname><given-names>PA</given-names></name><name><surname>Ng</surname><given-names>LFP</given-names></name></person-group><article-title>The trinity of COVID-19: immunity, inflammation and intervention</article-title><source>Nat Rev Immunol</source><year>2020</year><month>6</month><volume>20</volume><issue>(6)</issue><fpage>363</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">32346093</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannan</surname><given-names>A</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Rahman</surname><given-names>S</given-names></name><name><surname>Sohag</surname><given-names>AAM</given-names></name><name><surname>Dash</surname><given-names>R</given-names></name><name><surname>Hossain</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: crosstalk among calorie restriction, autophagy and immune response</article-title><source>Immunol Lett</source><year>2020</year><volume>226</volume><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">32659267</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-Vallesp&#x000ed;n</surname><given-names>B</given-names></name><name><surname>Vahjen</surname><given-names>W</given-names></name><name><surname>Zentek</surname><given-names>J</given-names></name></person-group><article-title>Effects of medium-chain fatty acids on the structure and immune response of IPEC-J2 cells</article-title><source>Cytotechnology</source><year>2016</year><month>10</month><volume>68</volume><issue>(5)</issue><fpage>1925</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">27553650</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faris</surname><given-names>MAIE</given-names></name><name><surname>Kacimi</surname><given-names>S</given-names></name><name><surname>Al-Kurd</surname><given-names>RA</given-names></name><name><surname>Fararjeh</surname><given-names>MA</given-names></name><name><surname>Bustanji</surname><given-names>YK</given-names></name><name><surname>Mohammad</surname><given-names>MK</given-names></name><etal/></person-group><article-title>Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects</article-title><source>Nutr Res</source><year>2012</year><season>Dec 01</season><volume>32</volume><issue>(12)</issue><fpage>947</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">23244540</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faris</surname><given-names>MAIE</given-names></name><name><surname>Jahrami</surname><given-names>HA</given-names></name><name><surname>Obaideen</surname><given-names>AA</given-names></name><name><surname>Madkour</surname><given-names>MI</given-names></name></person-group><article-title>Impact of diurnal intermittent fasting during Ramadan on inflammatory and oxidative stress markers in healthy people: systematic review and meta-analysis</article-title><source>J Nutr Intermed Metab</source><year>2019</year><season>Mar 01</season><volume>15</volume><fpage>18</fpage><lpage>26</lpage></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>JB</given-names></name><name><surname>June</surname><given-names>CH</given-names></name></person-group><article-title>Cytokine release syndrome in severe COVID-19</article-title><source>Science</source><year>2020</year><volume>368</volume><issue>(6490)</issue><fpage>473</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">32303591</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Narazaki</surname><given-names>M</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name></person-group><article-title>Immunotherapeutic implications of IL-6 blockade for cytokine storm</article-title><source>Immunotherapy</source><year>2016</year><volume>8</volume><issue>(8)</issue><fpage>959</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">27381687</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serreli</surname><given-names>G</given-names></name><name><surname>Deiana</surname><given-names>M</given-names></name></person-group><article-title>Extra virgin olive oil polyphenols: modulation of cellular pathways related to oxidant species and inflammation in aging</article-title><source>Cells</source><year>2020</year><volume>9</volume><issue>(2)</issue><fpage>478</fpage></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Schematic representation of a diet regimen proposed to dampen the SARS-CoV-2 infection by triggering metabolic switching. SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; MCFAs, medium-chain fatty acids; IF, intermittent fasting.</p></caption><graphic xlink:href="anm-0001-g01"/></fig></floats-group></article>